Clinical Trial

Emergent Large Vessel Occlusion Endovascular Rescue Therapy With Underlying Intracranial Stenosis

Study acronym: EVEREST
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The study objective is to establish the safety and efficacy of endovascular adjunct stenting for patients undergoing mechanical thrombectomy (MT) that are found to have residual stenosis (70-99%) following attempted clot retrieval with either aspiration catheters or stent retrievers, per device instructions for use and device labeling.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-05-23
notable Primary completion pushed: 2029-06-01 -> 2030-06-01 2026-05-23
Trial Details
NCT Number NCT07356284
Lead Sponsor ProMedica Health System
Conditions Brain Stroke, Stenting Treatment, Acute Ischemic Stroke
Enrollment 342 participants
Start Date 2026-05-19
Primary Completion 2030-06-01 (estimated)
Study Completion 2030-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-22